The PASTEUR Act, which has broad bipartisan support, would incentivize companies to develop new antimicrobial and antifungal medicines by offering "subscription" contracts to manufacturers to provide full access to these medicines in federal healthcare programs.
Private equity firms have moved aggressively into the healthcare industry's more hidden niches: They are pouring billions into the business of clinical drug trials.
DUBLIN - The Board of Horizon Therapeutics plc confirms that it is engaged in highly preliminary discussions with Amgen Inc., Janssen Global Services, LLC and Sanofi which may or may not lead to an offer being made for the entire share capital of the company.